Boston Scientific Corp. (BSX)
42.91
-0.08
(-0.19%)
USD |
NYSE |
Nov 20, 10:20
Boston Scientific Cash from Operations (Quarterly) : 1.048B for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.048B |
| June 30, 2026 | 1.474B |
| March 31, 2026 | 348.00M |
| December 31, 2025 | 1.364B |
| September 30, 2025 | 1.343B |
| June 30, 2025 | 1.286B |
| March 31, 2025 | 541.00M |
| December 31, 2024 | 1.456B |
| September 30, 2024 | 1.002B |
| June 30, 2024 | 813.00M |
| March 31, 2024 | 164.00M |
| December 31, 2023 | 957.00M |
| September 30, 2023 | 698.00M |
| June 30, 2023 | 658.00M |
| March 31, 2023 | 190.00M |
| December 31, 2022 | 807.00M |
| September 30, 2022 | 471.00M |
| June 30, 2022 | 306.00M |
| March 31, 2022 | -58.00M |
| December 31, 2021 | 478.00M |
| September 30, 2021 | 467.00M |
| June 30, 2021 | 642.00M |
| March 31, 2021 | 284.00M |
| December 31, 2020 | 673.00M |
| September 30, 2020 | 643.00M |
| Date | Value |
|---|---|
| June 30, 2020 | 269.00M |
| March 31, 2020 | -77.00M |
| December 31, 2019 | 692.00M |
| September 30, 2019 | 502.00M |
| June 30, 2019 | 292.00M |
| March 31, 2019 | 350.00M |
| December 31, 2018 | 19.00M |
| September 30, 2018 | 501.00M |
| June 30, 2018 | -403.00M |
| March 31, 2018 | 193.00M |
| December 31, 2017 | 872.00M |
| September 30, 2017 | 264.00M |
| June 30, 2017 | 176.00M |
| March 31, 2017 | 114.00M |
| December 31, 2016 | 466.00M |
| September 30, 2016 | -31.00M |
| June 30, 2016 | 421.00M |
| March 31, 2016 | 116.00M |
| December 31, 2015 | 329.00M |
| September 30, 2015 | 408.00M |
| June 30, 2015 | 60.00M |
| March 31, 2015 | -197.00M |
| December 31, 2014 | 440.00M |
| September 30, 2014 | 346.00M |
| June 30, 2014 | 285.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Abbott Laboratories | 1.737B |
| Becton, Dickinson & Co. | 1.458B |
| Stryker Corp. | 1.461B |
| Insulet Corp. | 123.40M |
| The Cooper Cos., Inc. | 341.70M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -437.00M |
| Cash from Financing (Quarterly) | -569.00M |
| Free Cash Flow | 3.331B |
| Free Cash Flow Per Share (Quarterly) | 0.5978 |
| Free Cash Flow to Equity (Quarterly) | 1.539B |
| Free Cash Flow to Firm (Quarterly) | 953.46M |
| Free Cash Flow Yield | 5.36% |